WallStreetZenWallStreetZen

AnalystsEdward Nash
Edward Nash's Stock Forecasts

Analyst Ranking
Bottom 18%
#3594 out of 4337 analysts
Average Return
-2.72%
Win Rate
40%16 out of 40
Risk vs Reward
Poor
Good

Edward Nash's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ventyx Biosciences IncVTYX
+148.19%$13.57$33.68
2022-03-31 -
2023-03-30
Strong Buy
Verona Pharma PLCVRNA
+137.90%$5.25$12.49
2021-11-12 -
2022-11-11
Strong Buy
Amryt Pharma PLCAMYT
+92.60%$7.57$14.58
2022-09-06 -
2023-01-10
Strong Buy
Theratechnologies IncTHTX
+87.50%$7.68$14.40
2020-04-15 -
2021-04-15
Strong Buy
Uniqure NvQURE
+80.80%$34.84$62.99
2018-05-24 -
2019-05-24
Strong Buy

Edward Nash's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Verona Pharma PLCVRNA
3Strong Buy$35.00+111.35%Reiterates
a month ago
Corcept Therapeutics IncCORT
2Strong Buy$35.00+8.29%Maintains
a month ago
Intercept Pharmaceuticals IncICPT
6Strong Buy$20.00+91.57%Maintains
2 months ago
Travere Therapeutics IncTVTX
5Strong Buy$35.00+334.78%Maintains
2 months ago
Madrigal Pharmaceuticals IncMDGL
4Strong Buy$336.00+122.61%Reiterates
2 months ago
Theratechnologies IncTHTX
4Hold$8.00+283.14%Assumes
3 months ago
Dice Therapeutics IncDICE
3Hold$48.00+0.95%Downgrades
3 months ago
Cardiol Therapeutics IncCRDL
2Strong Buy$6.00+569.64%Maintains
4 months ago
Pliant Therapeutics IncPLRX
1Strong Buy$48.00+229.22%Initiates Coverage On
4 months ago
Akero Therapeutics IncAKRO
3Strong Buy$59.00+30.07%Maintains
4 months ago
Oramed Pharmaceuticals IncORMP
2Hold$2.00-22.78%Maintains
4 months ago
Ventyx Biosciences IncVTYX
3Strong Buy$54.00+59.43%Maintains
8 months ago
Amryt Pharma PLCAMYT
2Hold$17.00+15.65%Downgrades
9 months ago
Galmed Pharmaceuticals LtdGLMD
2Hold$15.00N/ADowngrades
a year ago
Chemocentryx IncCCXI
2Hold$52.00N/ADowngrades
a year ago
Rezolute IncRZLT
1Strong Buy$17.00N/AAssumes
a year ago
Obseva SaOBSVF
1Strong Buy$12.00N/AInitiates Coverage On
a year ago
Morphic Holding IncMORF
1Strong Buy$68.00N/AInitiates Coverage On
a year ago
Metacrine IncMTCR
1Hold$1.00N/ADowngrades
2 years ago
Adverum Biotechnologies IncADVM
2HoldN/AN/ADowngrades
5 years ago
Ultragenyx Pharmaceutical IncRARE
2Strong Buy$54.00N/AMaintains
5 years ago
Entasis Therapeutics Holdings IncETTX
1Strong Buy$20.00N/AInitiates Coverage On
5 years ago
Uniqure NvQURE
1Strong Buy$48.00N/AInitiates Coverage On
5 years ago
Abeona Therapeutics IncABEO
1Strong Buy$650.00N/AInitiates Coverage On
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.